Results 91 to 100 of about 12,163 (157)

Recombinant BCG-LTAK63 Vaccine Candidate for Tuberculosis Induces an Inflammatory Profile in Human Macrophages. [PDF]

open access: yesVaccines (Basel), 2022
Dos Santos CC   +8 more
europepmc   +1 more source

[BCG vs. BCG plus recombinant alpha-interferon 2b in superficial tumors of the bladder].

open access: yesArchivio italiano di urologia, andrologia : organo ufficiale [di] Societa italiana di ecografia urologica e nefrologica, 1995
BCG intravesical instillation is a well established therapy for superficial bladder carcinoma as adjuvant and/or prophylactic treatment. However side-effects are frequent when full doses are employed and therefore low dose alternative schedules were proposed.
E, Bercovich   +3 more
openaire   +1 more source

Recombinant BCG expressing the LTAK63 adjuvant improves a short-term chemotherapy schedule in the control of tuberculosis in mice. [PDF]

open access: yesFront Immunol, 2022
Trentini MM   +6 more
europepmc   +1 more source

Expression of recombinant antigen in BCG.

open access: yes, 2000
Little is known about the effect of different modes of expression of an antigen in rBCG on immune response. An appropriate wing of the immune system, with different degrees, is activated upon encounter with a foreign antigen. Knowledge of these responses is vital to the development of future recombinant vaccine. Various E.
openaire   +1 more source

Recombinant BCG-Prime and DNA-Boost Immunization Confers Mice with Enhanced Protection against Mycobacterium kansasii. [PDF]

open access: yesVaccines (Basel), 2021
Komine-Aizawa S   +5 more
europepmc   +1 more source

Mycobacterium bovis Wild-Type BCG or Recombinant BCG Secreting Murine IL-18 (rBCG/IL-18) Strains in Driving Immune Responses in Immunocompetent or Immunosuppressed Mice. [PDF]

open access: yesVaccines (Basel), 2022
Fol M   +7 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy